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ABSTRACT: A one-year-old domestic shorthair male cat was presented to the clinic with severe dyspnoea. The cat has a 
history of recurrence bronchial disease with coughing as a major clinical sign. The cat never be  hospitalized and clinical 
symptoms will disappear after antibiotic and glucocorticoid administration within a few days. On physical examination, the cat 
was dehydrated and apathetic. Dullness thoracic percussion was detected. Other organs out of thorax did not show abnormali-
ty. Thoracic radiography revealed pleural effusion. Purulent fluid was obtained by thoraco centesis and cytologic examination 
result was septic exudates. Hematological result was marked leukocytosis (59.69x10ˆ9 g/l). Enrofloxacin was given as empiri-
cal antibiotic until culture results released. On the 7
th
 day of Enrofloxacin administration, there was only a slight decrease in 
leucocyte count. Bacterial culture results was Acinetobacter baumannii (A. baumanii) that are sensitive to Meropenem and 
Tigecycline from antibiotic resistance test. Previous antibiotic was stopped and replaced with intravenous Meropenem. Mod-
erate decrease of leucocytes count (28.03x10ˆ9 g/l) obtained on day 18
th
 of Meropenem treatment and patient shows good clin-
ical sign progress. Meropenem resistancy were considered when leucocytes count increased on the 20
th
 day as A. baumanii is 
extremely multi-resistant organism. Third-line Tigecycline was administered as the last choice use of antibiotic and stop after 
leucocyte returned to normal on the 7
th
 day of the treatment. The cat is fully recovered from Acinetobacter Baumannii infec-
tion pyothorax treated using third-line Tigecycline antibiotics. 
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■ CASE 
A 1-year-old, male DSH cat was presented to the clinic due 
to severe dyspnoe and anorexia. The cat has a history of a 
few months recurrence coughing and diagnosed as a mild 
tracheobronchitis. Clinical signs dissapear with first line 
antibiotic and low dose glucocorticoid. During physical 
examination the cat was dehydration, apatethic and dullness 
thoracic percussion was detected. 
 
■ RESULTS 
Haematological results show dehydration polycythaemia 
and marked leucocytosis (59.69x10ˆ9 g/l) indicating severe 
bacterial infection (Fig. 1). Thoracic radiograph revealed 
pleural efusion (Fig. 2) and purulent exudates was removed 
from pleura through thoraco centesis procedure. The cat 
receive enrofloxacin 5 mg/kg bb sid until culture result 
released. 
On 7
th 
days enrofloxacin, cat’s condition worsen and the 
WBCs count does not show significance change (Fig. 1). 
The culture result revealed Acinetobacter baumannii as a 
pathogen cause. Antibiotic resistancy results only 
Meropenem (MIC ≤ 0.25) and Tigecycline (MIC ≤ 0.50) are 
susceptible antibiotic. Meropenem was choosen for this 
case. Consideration is due to the lowest MIC and to 
preserved the use of Tigecycline as a last choice.  
 
Figure 1. WBCs progression during antibiotic treatment. 
On 18
th
 days of Meropenem, WBCs count decreas a half 
from initial treatment (Fig. 1), the cat also seems fully 
recoverd. Haematological evaluation was expected to be 
normal at the end of treatment period. However, WBCs has 
mild increasing at 20
th
 days of therapy. The cat shows no 
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abnormality but thoracic radiographed revealed effusion 
still remain on cranial pleural cavities (Fig. 2). 
 
Figure 2. Thoracalis radiographic in dorso-ventral view (A,C,E) 
and latero-lateral requmbency view (B,D,F) of the patient pre 
treatment (A,B); 18
th
 days of Meropenem treatment (C,D); and 7
th
 
days of Tigecycline treatment (E,F). 
The haematological changes and radiograph results is the 
main consideration of a high risk of A. baumannii 
developing resistancy. Antibiotic then switched to 
Tigecycline with human paediatric dose at 2 mg/kg BW in 
100 ml NaCl 0.9% as a CRI 30 min every 12 hours on first 
day of initial treatment. The dosage divide into 1 mg/kg BW 
every 12 hours CRI 30 min for the next 6
th
 days. WBCs 
count comes back to normal range in 7
th
 days of Tigecycline 
treatment (Fig. 1), and thorax radiograph significantly clear 
(Fig. 2). The cat fully recover and owner claimed no 
reccurence clinical signs again. 
■ DISCUSSION 
A.baumannii is Gram-negative aerobic coccobacillus and 
was part of ESKAPE pathogen (Enterococcus faecium, 
Staphylococcus aureus, Klebsiella pneumoniae, 
Acinetobacter baumannii, Pseudomonas aeruginosa and 
Enterobacter spp). Its a highly multi-, extended- or pan-
drug resistant strains. A. baumannii known as a widespread 
nosocomial pathogen in human hospital (Howard et al. 
2012). Third-line antibiotics is use for treatment of 
multidrug-resistant organisms. These antibiotics must only 
be used when there is culture evidence of sensitivity, no 
first- or second-line antibiotics are effective, and topical 
antimicrobial therapy is not feasible or effective (Authier et 
al. 2006). Tigecycline is the first drug in the glycylcycline 
class of tetracycline antibiotics. It has a broad spectrum of 
activity against many Gram positif, Gram negative and 
anaerobic organism. It was develop as a third line antibiotic 
against high resistance microbes (Greer 2006).  
The initial cause of the cat infected with A. baumannii 
until pyothorax was develop remains unclear. The cat never 
been hospitalizedand stay as an indoor cat with no bite 
wound incident history as the owner claimed. The owner 
works as a professional medical personelat various general 
human hospitals. It might increase repetition exposure of 
A.baumannii to the cat when she comes home from 
working. The cat might also under immunocompromise, 
increasing the risk of excacerbatemild bronkhitis develop 
into pyothorax in few months. However these possibility 
and another port the entry need to be fully investigated. 
■ CONCLUSION 
The cat is fully recovered from Acinetobacter Baumannii 
infection pyothorax treated using third-line Tigecycline 
antibiotics. 
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